The Conversation (0)
FluoroPharma Medical Inc. (OTCQB:FPMI) has been elected to the Medical Imaging & Technology Alliance (MITA) and will be represented by Edward L. Lyons, Vice President of Marketing.
FluoroPharma Medical Inc. (OTCQB:FPMI) has been elected to the Medical Imaging & Technology Alliance (MITA) and will be represented by Edward L. Lyons, Vice President of Marketing.
As quoted in the press release:
Mr. Lyons is responsible for the global development and commercial strategy for FluoroPharma’s nuclear cardiology portfolio.
MITA, a division of the National Electrical Manufacturers Association (NEMA), is the leading organization and collective voice of medical imaging equipment, radiation therapy and radiopharmaceutical manufacturers, innovators and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology.
FluoroPharma Medical Inc. Chairman and CEO, Thijs Spoor, said:
FluoroPharma is pleased and proud to become a member of this important organization. MITA is a key advocate for our industry as medical diagnostic products are playing an ever increasing role in the detection, diagnosis and treatment of disease. We are delighted to have Ed Lyons represent both our company as well as cardiac patients’ interests at MITA.
Click here to read the FluoroPharma Medical Inc. (OTCQB:FPMI) press release
